This Week in Managed CareCMS Drug Coverage Changes Draw Ire and Other Health News

Published: Nov. 30, 2018, 10 a.m.

b'Every week, The American Journal of Managed Care\\xae recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.\\n\\nThis week, the top managed care news included\\xa0a CMS plan for changes in drug coverage that brought a wave of criticism;\\xa0a government task force recommended more people at risk for HIV take pre-exposure prophylaxis, known as PrEP;\\xa0the American College of Cardiology issued an Expert Consensus Pathway on treatment of patients with type 2 diabetes and atherosclerotic cardiovascular disease.\\n\\nRead more about the stories in this podcast:\\nCMS Aims at Drug Prices Through Part D, MA Step Therapy, Pharmacy Rebates: https://www.ajmc.com/newsroom/cms-aims-at-drug-prices-through-part-d-ma-step-therapy-pharmacy-rebates\\nCMS Finalizes New Structure to Move Home Health to Value-Based Payment: https://www.ajmc.com/newsroom/cms-finalizes-new-structure-to-move-home-health-to-valuebased-payment\\nUSPSTF Recommends Clinicians Prescribe HIV PrEP to All High-Risk Patients: https://www.ajmc.com/newsroom/uspstf-recommends-clinicians-prescribe-hiv-prep-to-all-highrisk-patients\\nACC Pathway Finds Empagliflozin "Preferred" SGLT2 Therapy for Patients With Type 2 Diabetes, ASCVD: https://www.ajmc.com/newsroom/acc-pathway-finds-empagliflozin-preferred-sglt2-therapy-for-patients-with-type-2-diabetes-ascvd\\nAmerican Society of Hematology Annual Meeting & Exposition: https://www.ajmc.com/conferences/ash-2018\\nTwitter: @EBOncology:\\xa0https://twitter.com/eboncology'